Wim Lemahieu

1.5k total citations
17 papers, 654 citations indexed

About

Wim Lemahieu is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Nephrology. According to data from OpenAlex, Wim Lemahieu has authored 17 papers receiving a total of 654 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Pediatrics, Perinatology and Child Health and 6 papers in Nephrology. Recurrent topics in Wim Lemahieu's work include Pharmacological Effects and Toxicity Studies (8 papers), Drug Transport and Resistance Mechanisms (7 papers) and Renal Transplantation Outcomes and Treatments (6 papers). Wim Lemahieu is often cited by papers focused on Pharmacological Effects and Toxicity Studies (8 papers), Drug Transport and Resistance Mechanisms (7 papers) and Renal Transplantation Outcomes and Treatments (6 papers). Wim Lemahieu collaborates with scholars based in Belgium and Norway. Wim Lemahieu's co-authors include Bart Maes, Kristin Verbeke, Yves Vanrenterghem, Karel Geboes, Yves Vanrenterghem, Anders Åsberg, Hallvard Holdaas, Monica Hermann, Paul Rutgeerts and Sara Ombelet and has published in prestigious journals such as Kidney International, American Journal of Kidney Diseases and American Journal of Transplantation.

In The Last Decade

Wim Lemahieu

16 papers receiving 628 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Wim Lemahieu 295 188 151 144 106 17 654
Jill Martin 224 0.8× 77 0.4× 73 0.5× 331 2.3× 49 0.5× 38 641
Olusegun Famure 478 1.6× 93 0.5× 44 0.3× 324 2.3× 74 0.7× 56 814
Maxence Ficheux 301 1.0× 243 1.3× 69 0.5× 203 1.4× 83 0.8× 62 955
Rachel C. Forbes 190 0.6× 40 0.2× 42 0.3× 158 1.1× 51 0.5× 55 675
Rahul Mainra 128 0.4× 69 0.4× 45 0.3× 107 0.7× 56 0.5× 38 662
Chulaporn Limwattananon 139 0.5× 61 0.3× 16 0.1× 168 1.2× 26 0.2× 40 555
Nicholas Cross 283 1.0× 58 0.3× 70 0.5× 200 1.4× 29 0.3× 30 731
Dean Collier 66 0.2× 54 0.3× 71 0.5× 404 2.8× 17 0.2× 41 886
Şehsuvar Ertürk 114 0.4× 50 0.3× 46 0.3× 284 2.0× 19 0.2× 61 1.1k
R. S. Nanra 51 0.2× 97 0.5× 37 0.2× 162 1.1× 37 0.3× 46 848

Countries citing papers authored by Wim Lemahieu

Since Specialization
Citations

This map shows the geographic impact of Wim Lemahieu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wim Lemahieu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wim Lemahieu more than expected).

Fields of papers citing papers by Wim Lemahieu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wim Lemahieu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wim Lemahieu. The network helps show where Wim Lemahieu may publish in the future.

Co-authorship network of co-authors of Wim Lemahieu

This figure shows the co-authorship network connecting the top 25 collaborators of Wim Lemahieu. A scholar is included among the top collaborators of Wim Lemahieu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wim Lemahieu. Wim Lemahieu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Laurent, Michaël R., Jolan Dupont, Wim Lemahieu, et al.. (2025). Treatment of Osteoporosis in Patients with Chronic Kidney Disease. Current Osteoporosis Reports. 23(1). 26–26.
2.
Claes, Kathleen, et al.. (2022). Atypical Hemolytic Uremic Syndrome Occurring After Receipt of mRNA-1273 COVID-19 Vaccine Booster: A Case Report. American Journal of Kidney Diseases. 81(3). 364–367. 13 indexed citations
3.
Frans, Eric, Sara Ombelet, Wim Lemahieu, et al.. (2020). Frailty and Mortality in Hospitalized Older Adults With COVID-19: Retrospective Observational Study. Journal of the American Medical Directors Association. 21(7). 928–932.e1. 117 indexed citations
4.
Lemahieu, Wim, Sara Ombelet, Evelyne Lerut, Sofie Jamar, & Ben Sprangers. (2018). Reversal of Dialysis-Dependent Anti–Glomerular Basement Membrane Disease Using Plasma Exchange, Glucocorticosteroids, and Rituximab. Kidney International Reports. 3(5). 1229–1232. 5 indexed citations
5.
Peeters, Patrick, Wim Van Biesen, Nic Veys, et al.. (2016). External Validation of a risk stratification model to assist shared decision making for patients starting renal replacement therapy. BMC Nephrology. 17(1). 41–41. 10 indexed citations
6.
Lemahieu, Wim, et al.. (2014). High anion gap metabolic acidosis: use the proper acronym, discard the red herrings and thou shall find the culprit. Clinical Kidney Journal. 7(3). 320–322. 6 indexed citations
7.
Lemahieu, Wim & Bart Maes. (2007). In Vivo Assessment of Cytochrome P450 3A4 and P-Glycoprotein Activity:Impact on Clinical Practice. Current Enzyme Inhibition. 3(3). 217–241. 3 indexed citations
8.
Jonge, Hylke de, Bert Bammens, Wim Lemahieu, Bart Maes, & Yves Vanrenterghem. (2006). Comparison of peritoneal dialysis and haemodialysis after renal transplant failure. Nephrology Dialysis Transplantation. 21(6). 1669–1674. 46 indexed citations
9.
Lemahieu, Wim, Bart Maes, Kristin Verbeke, & Yves Vanrenterghem. (2005). Impact of gastric acid suppressants on cytochrome P450 3A4 and P-glycoprotein: Consequences for FK506 assimilation. Kidney International. 67(3). 1152–1160. 18 indexed citations
10.
Lemahieu, Wim, Monica Hermann, Anders Åsberg, et al.. (2005). Combined Therapy with Atorvastatin and Calcineurin Inhibitors: No Interactions with Tacrolimus. American Journal of Transplantation. 5(9). 2236–2243. 113 indexed citations
11.
Lemahieu, Wim, Bart Maes, & Yves Vanrenterghem. (2005). Different Evolution of Trough and Dose Levels During the First Year After Transplantation for Tacrolimus Versus Cyclosporine. Transplantation Proceedings. 37(5). 2051–2053. 11 indexed citations
12.
Lemahieu, Wim, Bart Maes, Kristin Verbeke, et al.. (2005). Cytochrome P450 3A4 and P-glycoprotein Activity and Assimilation of Tacrolimus in Transplant Patients with Persistent Diarrhea. American Journal of Transplantation. 5(6). 1383–1391. 94 indexed citations
13.
Lemahieu, Wim, Bart Maes, Kristin Verbeke, & Yves Vanrenterghem. (2004). Alterations of CYP3A4 and P-glycoprotein activity in vivo with time in renal graft recipients. Kidney International. 66(1). 433–440. 20 indexed citations
14.
Lemahieu, Wim, Bart Maes, Kristin Verbeke, & Yves Vanrenterghem. (2004). CYP3A4 and P-Glycoprotein Activity in Healthy Controls and Transplant Patients on Cyclosporin vs. Tacrolimus vs. Sirolimus. American Journal of Transplantation. 4(9). 1514–1522. 69 indexed citations
15.
Dalle, Ignace, Bart Maes, Karen Geboes, Wim Lemahieu, & Karel Geboes. (2004). Crohn's‐like changes in the colon due to mycophenolate?. Colorectal Disease. 7(1). 27–34. 52 indexed citations
16.
Lemahieu, Wim, Bart Maes, Yvo Ghoos, et al.. (2003). Measurement of hepatic and intestinal CYP3A4 and PGP activity by combined po + iv [14C]erythromycin breath and urine test. American Journal of Physiology-Gastrointestinal and Liver Physiology. 285(3). G470–G482. 24 indexed citations
17.
Maes, Bart, Wim Lemahieu, Dirk Kuypers, et al.. (2002). Differential Effect of Diarrhea on FK506 Versus Cyclosporine A Trough Levels and Resultant Prevention of Allograft Rejection in Renal Transplant Recipients. American Journal of Transplantation. 2(10). 989–992. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jill Martin Breakdown of academic impact, for papers by Olusegun Famure Breakdown of academic impact, for papers by Maxence Ficheux Breakdown of academic impact, for papers by Rachel C. Forbes Breakdown of academic impact, for papers by Rahul Mainra Breakdown of academic impact, for papers by Chulaporn Limwattananon Breakdown of academic impact, for papers by Nicholas Cross Breakdown of academic impact, for papers by Dean Collier Breakdown of academic impact, for papers by Şehsuvar Ertürk Breakdown of academic impact, for papers by R. S. Nanra
Rankless by CCL
2026